We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Protein Prods Cancer-fighting T Cells

News   Jan 10, 2019 | Original story from University of Washington

 
Protein Prods Cancer-fighting T Cells

The new immunotherapy drug is designed to fight cancer while avoiding common side effects. This illustration depicts how the new protein, in red, binds only to the beta and gamma receptors, and not to cells with a third kind of receptor. Credit: Institute for Protein Design

 
 
Advertisement
 

RELATED ARTICLES

Anti-malarial Drug Shows Promise in First Clinical Trial

News

A fast-acting anti-malarial compound was shown to be well tolerated and displayed promising anti-malarial effects in the first study in humans.

READ MORE

Cellular Cleanup Gone Wrong Could Lead to Lifelong Behavioral Problems

News

Improper removal of faulty brain cells during neurodevelopment may cause lifelong behavioral issues, according to researchers.

READ MORE

Protein Target for Future Antidepressants Identified

News

A recent study strongly suggests that the protein GPR56 is involved in the biology of depression, which could offer a novel target for new antidepressant drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE